Literature DB >> 19551819

Seroprevalence, risk factors, and hepatitis C virus genotypes in groups with high-risk sexual behavior in Croatia.

Tatjana Vilibic Cavlek1, Ira Gjenero Margan, Snjezana Zidovec Lepej, Branko Kolaric, Adriana Vince.   

Abstract

The seroprevalence, risk factors and genotypes of hepatitis C virus (HCV) in groups with high-risk sexual behavior (persons with multiple sexual partners, men who have sex with men, commercial sex workers and their clients and persons with sexually transmitted diseases) in seven Croatian cities were analyzed. A total of 821 participants without history of injecting drug use were included in the study. Anti-HCV prevalence among risk groups varied from 2.9% to 8.5% with an overall prevalence of 4.6% (95% CI = 3.2-6.1) compared with 0.5% (95% CI = 0.0-1.5) in controls (pregnant females; OR = 9.66; 95% CI = 1.32-70.7). HCV-RNA was detected in 73.1% anti-HCV positive patients. Three of the seronegative cases (2.1%) were also found to be HCV-RNA positive ("window period"). Genotype 1 was most commonly detected (55.6%). The most prevalent subtypes were 1a (38.9%) and 3a (38.9%). Sociodemographic characteristics (age, gender, marital status and level of education) were not associated with anti-HCV seropositivity. Among sexually transmitted disease markers, a higher seroprevalence of HCV infection was found in subjects with a history of HBV infection (10.5% vs. 3.8%, P = 0.002) and gonorrhea (13.2% vs. 4.2%, P = 0.011). No other factors reflecting risk sexual behavior such as sexual orientation, number of sexual partners and number of risk behaviors were associated with HCV seroprevalence. 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19551819     DOI: 10.1002/jmv.21530

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

Review 1.  Epidemiology of hepatitis C in Croatia in the European context.

Authors:  Tatjana Vilibic-Cavlek; Jasmina Kucinar; Bernard Kaic; Maja Vilibic; Nenad Pandak; Ljubo Barbic; Vladimir Stevanovic; Jasmina Vranes
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Distribution of hepatitis c virus (hcv) genotypes in patients with chronic infection from Rondônia, Brazil.

Authors:  Deusilene S Vieira; Mónica V Alvarado-Mora; Lívia Botelho; Flair J Carrilho; João Rr Pinho; Juan M Salcedo
Journal:  Virol J       Date:  2011-04-12       Impact factor: 4.099

3.  Treatment of chronic hepatitis C in Croatian war veterans: experiences from Croatian reference center for viral hepatitis.

Authors:  Neven Papić; Snježana Židovec Lepej; Ivan Kurelac; Vjeran Čajić; Jelena Budimir; Davorka Dušek; Adriana Vince
Journal:  Croat Med J       Date:  2011-02       Impact factor: 1.351

4.  The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.

Authors:  Boris Kauhl; Jeanne Heil; Christian J P A Hoebe; Jürgen Schweikart; Thomas Krafft; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 5.  Hepatitis B/C in the countries of the EU/EEA: a systematic review of the prevalence among at-risk groups.

Authors:  Abby May Falla; Sanne Henrietta Ina Hofstraat; Erika Duffell; Susan Josien Maria Hahné; Lara Tavoschi; Irene Karen Veldhuijzen
Journal:  BMC Infect Dis       Date:  2018-02-12       Impact factor: 3.090

6.  How close are we to hepatitis C virus elimination in Central Europe?

Authors:  Robert Flisiak; Sona Frankova; Ivica Grgurevic; Bela Hunyady; Peter Jarcuska; Limas Kupčinskas; Michael Makara; Marieta Simonova; Jan Sperl; Ieva Tolmane; Adriana Vince; Dorota Zarębska-Michaluk
Journal:  Clin Exp Hepatol       Date:  2020-02-17

Review 7.  Hepatotropic viruses: Is Roma population at risk?

Authors:  Anna Mrzljak; Lucija Bajkovec; Tatjana Vilibic-Cavlek
Journal:  World J Gastroenterol       Date:  2021-01-14       Impact factor: 5.742

8.  AIDS and hepatitis B and C high risk behaviors among 15 to 45 years old individuals in Bandar Abbas (Iran) in 2012.

Authors:  Mahin Jamshidi Makiani; Parivash Davoodian; Farshid Abedi; Mahtab Hossini; Shahram Zare; Shafea Rahimi; Keramat Allah Jahanshahi; Tasnim Eqbal Eftekhari
Journal:  Electron Physician       Date:  2014-07-01

Review 9.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.